← FDA Drug Approvals (Drugs@FDA)
METHYLPREDNISOLONE ACETATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WILSHIRE PHARMS INC · Approved 2023-01-03
Drug application
- FDA Application #
ANDA214870- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- METHYLPREDNISOLONE ACETATE
- Generic name
- METHYLPREDNISOLONE ACETATE
- Active ingredients
- METHYLPREDNISOLONE ACETATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- WILSHIRE PHARMS INC
- Manufacturer
- Sandoz Inc.
- First approval
- 2023-01-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown